-
Be Part of the 2021 Arrowhead SBIR/STTR Cohort
November 09, 2020
his 12-week NIH SBIR/STTR application development cohort includes in-depth guidance on various topics.
Read article -
I-Corps Team Turning Heat Into Ice!
November 09, 2020
In remote Ӱ communities where heat often goes straight up the flue pipe, that heat could be turned into solid gold, as ice!
Read article -
November 09, 2020
Startup Week brings entrepreneurs, local leaders and friends together for one week to build momentum around Ӱ’s entrepreneurial opportunities.
Read article -
I-Corps Team Turning Heat Into Ice!
November 09, 2020
In remote Ӱ communities where heat often goes straight up the flue pipe, that heat could be turned into solid gold, as ice!
Read article -
ASCEND Webinar – SBIR/STTR Phase II: Moving your innovative idea towards commercialization
November 09, 2020
Want to learn more about SBIR/STTR Phase II funding and applications? Join the noon Thursday, Nov. 12 Ascend Webinar presented by Del Mackey.
Read article -
Be Part of the 2021 Arrowhead SBIR/STTR Cohort
November 09, 2020
his 12-week NIH SBIR/STTR application development cohort includes in-depth guidance on various topics.
Read article -
ICE Jam Event Uncovers Investment and Startup Opportunities
November 09, 2020
Center ICE partnered with the Ӱ Angel Conference to host an engaging online event about “Investing and Raising Capital During the Pandemic.”
Read article -
ASCEND Biomedical Commercialization Short Course
October 06, 2020
ASCEND is offering a virtual, multi-site course, “Bridging the Gap: Commercialization for Biomedical Researchers” for the Western IDeA states.
Read article -
2021 IDEAs Award Winners Give Hope for Stroke and Heart Attack Victims
October 06, 2020
Recent Ӱ research found that drugs may be used to control the metabolic rate after cardiac arrest and stroke to improve survival and neurological outcomes.
Read article -
ASCEND Biomedical Commercialization Short Course
October 06, 2020
ASCEND is offering a virtual, multi-site course, “Bridging the Gap: Commercialization for Biomedical Researchers” for the Western IDeA states.
Read article